Pandemic may have altered gut microbiome of infants, study finds

Share this article GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug

NS Phar­ma’s Duchenne mus­cu­lar dy­s­tro­phy drug Vil­tep­so failed its con­fir­ma­to­ry study. De­spite the fail­ure, the com­pa­ny is keep­ing faith in the drug and run­ning fur­ther

Pre­clin­i­cal da­ta sug­gest that Mod­er­na’s mpox vac­cine could be su­pe­ri­or to oth­er al­ter­na­tives cur­rent­ly ap­proved, ac­cord­ing to new re­search pub­lished Wednes­day. Sci­en­tists Sign up to